Showing results (31-40 of 434) with videos related to
Sort By:
Pageof 44
Cancer Journal (Sudbury, Mass.)|February 4, 2016
Monoclonal Antibodies for the Treatment of Myeloma: Targeting SLAMF7 and CD38Sagar LonialCancer Biology & Therapy|June 2, 2016
Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myelomaKatelyn G Ponder, Shannon M Matulis, Sadae Hitosugi, et al.Clinical Lymphoma, Myeloma & Leukemia|May 9, 2025
Feasibility and Safety of Outpatient Model for Administration of Bispecific Antibodies: Proceedings from an International Myeloma Society 21st Annual Meeting Oral AbstractSara A Scott, Danielle L Roberts, Vikas A Gupta, et al.Cancer Journal (Sudbury, Mass.)|September 22, 2021
Maintenance Strategies for Myeloma: Is Bigger Always Better?Ajay K Nooka, Nisha S JosephHaematologica|September 4, 2025
Infection risk in 158 patients with relapsed/refractory multiple myeloma treated with bispecific antibodies: a single-center experienceLorenzo Cani, Sara A Scott, Danielle Roberts, et al.Hematology/Oncology Clinics of North America|September 13, 2014
Relapsed and refractory multiple myeloma: new therapeutic strategiesSilvia Gentili, Sagar LonialBiologics : Targets & Therapy|August 27, 2009
Clinical uses of GM-CSF, a critical appraisal and updateMartha Arellano, Sagar LonialHematological Oncology|March 8, 2008
Review of peripheral neuropathy in plasma cell disordersJeannine Silberman, Sagar LonialBritish Journal of Haematology|April 7, 2009
Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myelomaSagar Lonial, Jamie CavenaghPageof 44